Ultrasonix Medical Corporation Announces Improved Warranty Program
Ultrasonix Medical Corporation, a leading developer and manufacturer of high quality diagnostic ultrasound imaging systems, is pleased to announce today that it is improving its standard warranty program to 3 years on its entire product line
RICHMOND, British Columbia, Sept. 15 /PRNewswire/ -- Ultrasonix Medical Corporation, a leading developer and manufacturer of high quality diagnostic ultrasound imaging systems, is pleased to announce today that it is improving its standard warranty program to 3 years on its entire product line.
"In celebration of 10-years of providing our customers with innovative solutions and great service, as well as a growing demand in the global marketplace from customers for additional manufacturers protection, we are proud to announce that our product warranty will be extended by a full 24-months, to a total of 36-months, effective immediately," said Graham Coulter, VP Customer Services.
"This warranty extension is not only proof we stand behind our products but further demonstrates our commitment to bringing innovation and value to our customers," said Laurent Pelissier, CEO.
About Ultrasonix:
Ultrasonix (www.ultrasonix.com) is a leading developer and manufacturer of high quality diagnostic ultrasound imaging systems. The company's OpenSONIX ultrasound technology provides superior image quality, ease of use and clinical flexibility to adapt to the needs of a variety of specialties. Ultrasonix is a privately held, profitable company headquartered in Richmond, British Columbia with affiliate dealers in 65 countries.
Contact: Graham Coulter P Customer Services Ultrasonix Medical Corporation Tel: 604.279.8550 Fax: 604.279.8559 |
|
This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com
SOURCE Ultrasonix Medical Corporation
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article